CONDITION

Plasma Cell Pododermatitis in Cats

Plasma cell pododermatitis is an uncommon condition in cats where the footpads become infiltrated with a particular type of immune cell called a plasma cell. The central pad is most often affected, becoming soft, spongy, and visibly swollen. In many cases the surface may take on a smooth or slightly shiny appearance, and some cats develop ulceration or bleeding with time. Owners typically notice that one or more pads look larger or feel different in texture, sometimes described as marshmallow-like or puffy. The cat may or may not show signs of discomfort—some walk normally despite the visible change, while others limp or avoid putting weight on the affected foot. The condition can involve one pad or several, and tends to occur in middle-aged to older cats, though younger animals are sometimes affected. This page explores the signals that may be seen, what is understood about the underlying immune process, how the condition is investigated and confirmed, and the range of approaches used to manage it. The course is variable, and in some cats the changes resolve without intervention, while in others treatment is considered.

Why this matters now

Plasma cell pododermatitis tends to be diagnosed in middle-aged to older cats, typically between four and ten years of age, though cases have been reported in younger animals. No clear breed predisposition has been identified, and both male and female cats appear equally susceptible. The condition arises without obvious external trigger in most cases, though the immune dysregulation involved may be part of a broader picture that includes other immune-mediated or inflammatory conditions in some individuals.

The visible changes often develop gradually over weeks to months, with progressive swelling and softening of the affected pad. In some cats the condition stabilises at a particular stage and remains static for long periods, while in others the pad surface may ulcerate, bleed, or develop secondary infection. A proportion of cases resolve spontaneously without intervention, particularly when only one or two pads are involved, though the timeframe for resolution is unpredictable.

Signals & patterns

Early signals

Enlarged central footpad

The central or metacarpal pad on one or more feet may appear visibly larger than usual, often with a smooth or slightly rounded contour. The change can be subtle at first and may be noticed only when comparing feet or during routine grooming.

Soft or spongy texture

When handled, the affected pad often feels softer and more compressible than normal, sometimes described as marshmallow-like or puffy. This change in consistency can be detected before any obvious colour change or ulceration develops.

Pale or violet discolouration

The pad surface may take on a paler tone than the surrounding pads, or in some cases a faint violet or purplish hue becomes visible. The colour shift reflects the underlying infiltration of immune cells and altered blood flow within the tissue.

Slight reluctance to jump

Some cats show minor behavioural changes such as hesitating before jumping onto furniture or choosing lower routes, even when no obvious limping is present. This may reflect mild discomfort or altered sensation in the affected pad.

Later signals

Surface ulceration or crusting

As the condition progresses, the pad surface may break down, forming shallow ulcers or areas where tissue weeps or crusts over. These lesions can bleed with minor trauma or pressure, and the raw surface may attract secondary bacterial colonisation.

Visible limping or weight-shifting

Cats with more advanced or painful lesions may develop an obvious limp, favouring the affected limb or redistributing weight to spare the ulcerated pad. The degree of lameness often correlates with the extent of ulceration rather than the degree of swelling alone.

Multiple pads involved

In some cats the condition spreads to involve several pads across different feet, either sequentially or concurrently. This pattern suggests a more systemic immune process and tends to be associated with a longer or more variable course.

Click to read about the biological mechanisms

How this is usually investigated

Investigation typically begins with careful examination of the affected pads and a review of the cat's medical history, looking for patterns of onset, progression, and any concurrent signs elsewhere. The distinctive soft, spongy texture and appearance of the pads often raise suspicion, but confirmation relies on tissue sampling and microscopic examination. Additional tests may be considered to assess for concurrent immune or systemic conditions, particularly when multiple pads are involved or when the presentation is atypical.

Physical examination

Purpose: Direct palpation reveals the characteristic soft, spongy texture of the affected pad, and visual inspection identifies swelling, colour change, ulceration, or bleeding. The number of pads involved and the presence of lameness or pain on pressure can also be noted.
Considerations: While the clinical appearance can be highly suggestive, it cannot distinguish plasma cell infiltration from other causes of pad swelling or ulceration. Examination provides the context for further investigation but does not confirm the diagnosis on its own.

Fine-needle aspirate cytology

Purpose: A small needle is inserted into the swollen pad to collect cells for microscopic examination. The presence of large numbers of plasma cells in a background of inflammatory cells supports the diagnosis and can often confirm it without the need for more invasive sampling.
Considerations: Cytology is quick and usually well tolerated, but the quality of the sample can vary, and interpretation depends on collecting a representative area. In some cases the findings may be equivocal and biopsy is pursued for definitive confirmation.

Histopathology from biopsy

Purpose: A wedge or punch biopsy of the affected pad is taken under sedation or anaesthesia, providing tissue architecture that allows pathologists to confirm dense plasma cell infiltration and rule out neoplastic or infectious processes. This is regarded as the definitive diagnostic method when the clinical picture is unclear or cytology is inconclusive.
Considerations: Biopsy requires anaesthesia and leaves a wound that may bleed or become secondarily infected, particularly if the pad is already ulcerated. Healing can be slow, and the procedure is typically reserved for cases where non-invasive sampling has not provided clarity or where other diagnoses remain in question.

Blood tests

Purpose: Haematology and biochemistry profiles assess general health and may identify concurrent conditions, particularly immune-mediated disorders or protein abnormalities that can accompany plasma cell dysregulation. Serum protein electrophoresis may be performed if there is concern about systemic plasma cell disease.
Considerations: Blood tests are usually unremarkable in isolated plasma cell pododermatitis, and abnormalities, when present, tend to reflect concurrent disease rather than the pad condition itself. They provide context rather than diagnosis and are most useful when the clinical picture suggests broader involvement.

Infectious disease screening

Purpose: Testing for feline immunodeficiency virus (FIV) and feline leukaemia virus (FeLV) may be considered, as both can be associated with immune dysregulation and an increased risk of inflammatory or immune-mediated conditions. Results help frame the broader clinical context and may influence management choices.
Considerations: The majority of cats with plasma cell pododermatitis test negative for both viruses, and a positive result does not confirm causation. Screening is typically performed when retroviral status is unknown or when other clinical signs raise suspicion of underlying immunosuppression.

Options & trade-offs

Management is tailored to the individual cat and depends on the number of pads affected, the presence of ulceration or secondary infection, and whether the cat shows signs of discomfort or lameness. Some cases resolve without intervention, while others are managed with combinations of medical therapy, supportive care, and monitoring. Different owners and animals find different approaches workable, and the course of the condition can shift over time, prompting adjustments to the plan.

Observation without medical intervention

When the pads are swollen but not ulcerated, and the cat shows no lameness or discomfort, careful monitoring without active treatment may be chosen. This approach acknowledges the tendency for some cases to resolve spontaneously and avoids the risks and costs associated with medical therapy. Regular checks are made to detect any progression, ulceration, or secondary infection.

Trade-offs: This approach suits cats with minimal signs and owners comfortable with watchful waiting, but it carries the risk that ulceration or infection may develop without early intervention. It relies on close observation and a willingness to reassess if the picture changes, and may not be appropriate when multiple pads are affected or when progression is already evident.

Immunosuppressive therapy

Oral corticosteroids, such as prednisolone, are often used to reduce the plasma cell infiltrate and associated inflammation, with the dose tapered over weeks to months depending on response. In some cases, other immunosuppressive agents such as ciclosporin or chlorambucil are considered, particularly when steroid side effects are problematic or when the response is incomplete. The aim is to downregulate the inappropriate immune activity and allow the pad architecture to recover.

Trade-offs: Immunosuppressive drugs can be highly effective in reducing swelling and preventing progression, but they carry risks including increased susceptibility to infection, metabolic disturbances, and gastrointestinal upset. Long-term use requires monitoring and dose adjustment, and some cats do not tolerate the medications well or show incomplete resolution despite treatment.

Topical or supportive wound care

When ulceration or bleeding is present, gentle cleaning, protective dressings, or topical antimicrobial preparations may be used to manage secondary infection and support healing. Bandaging is often short-term and aimed at reducing trauma and contamination while medical therapy takes effect. Environmental modifications, such as soft bedding or reduced access to rough surfaces, can reduce mechanical stress on fragile pads.

Trade-offs: Topical care addresses secondary complications rather than the underlying immune process, and its effectiveness is limited when the plasma cell infiltrate remains active. Bandaging can be difficult to maintain in cats, who may remove dressings or find them distressing, and prolonged use can delay recognition of worsening ulceration.

Surgical excision

In cases where a single pad is severely affected, ulcerated, or unresponsive to medical therapy, partial or complete surgical removal of the pad may be considered. The procedure removes the diseased tissue and allows for definitive histopathological examination, though healing can be prolonged and the remaining tissue may be subject to mechanical stress during recovery.

Trade-offs: Surgery offers a direct solution when medical management has failed or when the pad is non-functional, but it carries the risks of anaesthesia, postoperative infection, and incomplete healing. It is less suitable when multiple pads are involved, and recurrence in other pads may still occur regardless of surgical intervention on one site.

Antimicrobial therapy for secondary infection

When ulceration is complicated by bacterial infection, a course of oral antibiotics may be prescribed, typically guided by culture and sensitivity testing if the infection is persistent or severe. The aim is to control secondary bacterial colonisation while other measures address the underlying immune process.

Trade-offs: Antibiotics treat the consequence rather than the cause, and their benefit is transient if the pad remains ulcerated or the immune infiltrate continues. Prolonged or repeated courses carry risks of antimicrobial resistance and gastrointestinal disturbance, and they do not prevent recurrence if the underlying condition is not managed.

Common misconceptions

Misconception:

"Plasma cell pododermatitis is caused by walking on rough surfaces or an injury to the pad."

Reality:

The condition arises from an internal immune dysregulation rather than external trauma or environmental surfaces. While rough ground or injury can worsen an already fragile pad, they do not trigger the plasma cell infiltration itself, which reflects a broader disturbance in immune control.

Misconception:

"All cases of plasma cell pododermatitis require long-term medication."

Reality:

A proportion of cases, particularly those involving one or two pads without ulceration, resolve spontaneously without any medical intervention. Treatment decisions are individualised, and the course of the condition is variable enough that some cats never require therapy while others benefit from prolonged immunosuppression.

Misconception:

"If one pad is affected, all the other pads will eventually become involved."

Reality:

While some cats do develop changes in multiple pads over time, many cases remain limited to one or two pads throughout the course of the condition. Progression is unpredictable and does not follow a fixed pattern, and isolated pad involvement can persist for months or years without spread.

Related conditions

Eosinophilic Granuloma Complex in Cats

Eosinophilic granuloma complex shares a pattern of immune-mediated tissue infiltration in cats, though the cell type involved differs—eosinophils rather than plasma cells. Both conditions can present as raised or ulcerated lesions and may occur in cats with underlying immune dysregulation.

Indolent Ulcer in Cats

Indolent ulcers are part of the eosinophilic granuloma complex and can occasionally be considered alongside plasma cell pododermatitis when a cat presents with persistent ulcerated lesions. The distribution differs—lip versus footpad—but both involve chronic immune-mediated changes in mucocutaneous tissue.

Sebaceous Adenitis

Sebaceous adenitis involves immune-mediated destruction of sebaceous glands in the skin, reflecting a broader pattern of tissue-specific immune targeting. Plasma cell pododermatitis may represent a similar process directed at the footpad, though the target tissue and cell populations differ.

Symmetric Lupoid Onychodystrophy

Symmetric lupoid onychodystrophy is an immune-mediated condition affecting the structures of the claws, and it shares with plasma cell pododermatitis a tendency to involve the distal limb. Cats with one immune-mediated disorder of the feet may occasionally show signs in adjacent structures, though the conditions remain distinct.

Feline Leukaemia Virus (FeLV)

Feline leukaemia virus can alter immune function in infected cats, and in some cases plasma cell pododermatitis has been reported in FeLV-positive animals. The virus may contribute to immune dysregulation that permits or promotes infiltrative lesions, though the majority of cases occur in cats without known retroviral infection.

Plasma cell pododermatitis sits within a broader landscape of immune-mediated and inflammatory conditions, and some cats with this diagnosis may show other signs of immune dysregulation over time. Understanding the range of approaches available, the natural variability in how the condition progresses, and the practicalities of different management strategies can help frame conversations as the picture evolves. Related content on immune and inflammatory health in cats explores these themes in more detail, and the course of the condition often becomes clearer with observation over weeks to months.